How to treat VAP due to MDR pathogens in ICU patients

BACKGROUND: The increasing occurrence of multidrug resistant (MDR) bacteria arises at a time when there is a lack of antibiotics active against these pathogens and few new antimicrobials are in the pipelines of the pharmaceutical industry. Treatment of ventilator-associated pneumonia (VAP) caused es...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnacho-Montero, José, Corcia-Palomo, Yael, Amaya-Villar, Rosario, Martin-Villen, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289192/
https://www.ncbi.nlm.nih.gov/pubmed/25430700
http://dx.doi.org/10.1186/1471-2334-14-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289192/
https://www.ncbi.nlm.nih.gov/pubmed/25430700
http://dx.doi.org/10.1186/1471-2334-14-135

Ejemplares similares